China NT Pharma's CEO Steps Down; Successor Named

MT Newswires Live
07/06

China NT Pharma's (HKG:1011) CEO Zhang Bozhi stepped down to devote more time to his personal and other affairs effective July 3, according to a same-day Hong Kong bourse filing.

Shares of the healthcare marketing company were up over 1% in Monday afternoon trading.

The company named NG, Andy Ching Kit, as its new CEO effective the same day. NG joined the company in 2018 and has held various positions including international business manager and general manager.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10